NeoGenomics Inc (MEX:NEO)
MXN 176.4 (0%) Market Cap: 34.15 Bil Enterprise Value: 38.75 Bil PE Ratio: 0 PB Ratio: 2.28 GF Score: 71/100

Neogenomics Inc at TD Cowen Healthcare Conference Transcript

Mar 03, 2026 / 06:10PM GMT
Release Date Price: MXN217.5
Daniel Brennan
Cowen and Company LLC - Analyst

(audio in progress) Live, welcome, day two of the TD Cowen and Global Healthcare Conference, 46th Annual.

I'm Dan Brennan. I follow Tools and Diagnostics. Pleased to be joined here on the stage with the management team of Neogenomics. To my left, for those in the audience here live, I've Tony Zook, Chief Executive Officer. To his left, we have, Abhishek Jain, who's the Chief Financial Officer, and then we have Warren Stone at the far end who's the Chief Operating Officer. Gentlemen, welcome and thank you for being here.

Tony Zook
Neogenomics Inc - Chief Executive Officer, Director

Thanks for having us.

Questions & Answers

Daniel Brennan
Cowen and Company LLC - Analyst

Yeah, maybe just, Tony, Warren, guys, why don't you just maybe zoom out a little bit. Quarter wasn't that long ago. You just set the guide for '26. Just maybe offer some introductory comments, some perspective on where Neo sits today and kind of how you're thinking about the next

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot